Recently Announced Funding Opportunities
On August 30, 2023, the Centers for Disease Control and Prevention (CDC) released CDC-RFA-CE-24-011: Grants to Support New Investigators in Conducting Research Related to Understanding Drug Use and Overdose Risk and Protective Factors.
The purpose of the CDC’s National Center for Injury Prevention and Control (NCIPC) Mentored Research Scientist Development Award (K01) is to provide support for an intensive, supervised/mentored career development experience in substance use and/or overdose prevention research leading to research independence. NCIPC supports K01 grants to help ensure the availability of an adequate number of trained scientists to address critical public health research questions to prevent polydrug use and overdose.
Pre-application teleconference call: October 10, 2023. A pre-application teleconference call will be conducted on October 10, 2023, to address questions from prospective applicants regarding NOFO RFA-CE-24-011. The call will begin at 2pm Eastern Standard Time (EST) and end at 3pm Eastern Standard Time (EST), or sooner if all questions have been addressed.
Letter of intent due: November 1, 2023. Letters of intent are requested by November 1, 2023. A letter of intent is not required, is not binding, and does not enter into the review of an application. The letter helps NCIPC staff plan for scientific and technical merit peer review.
Application due: December 1, 2023
On August 30, 2023, the Centers for Disease Control and Prevention (CDC) released CDC-RFA-CE-24-012: Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose.
Pre-application teleconference call: October 17, 2023. A pre-application teleconference call will be conducted on October 17, 2023, to address questions from prospective applicants regarding NOFO RFA-CE-24-012. The call will begin at 2pm Eastern Standard Time (EST) and end at 3pm Eastern Standard Time (EST), or sooner if all questions have been addressed.
Letter of intent due: November 1, 2023. Letters of intent are requested by November 1, 2023. A letter of intent is not required, is not binding, and does not enter into the review of an application. The letter helps NCIPC staff plan for scientific and technical merit peer review.
Application due: December 1, 2023
On August 30, 2023, the Centers for Disease Control and Prevention (CDC) released CDC-RFA-CE-24-013: Research Grants to Identify Effective Community-Based Strategies for Overdose Prevention.
Pre-application teleconference call: October 24, 2023. A pre-application teleconference call will be conducted on October 24, 2023, to address questions from prospective applicants regarding NOFO RFA-CE-24-013. The call will begin at 2pm Eastern Standard Time (EST) and end at 3pm Eastern Standard Time (EST), or sooner if all questions have been addressed.
Letter of intent due: November 1, 2023. Letters of intent are requested by November 1, 2023. A letter of intent is not required, is not binding, and does not enter into the review of an application. The letter helps NCIPC staff plan for scientific and technical merit peer review.
Application due: December 1, 2023
